EU regulators blast China’s Zhejiang Huahai over valsartan API mess
admin 28th September 2018 Uncategorised 0The European Medicines Agency has piled onto China’s Zhejiang Huahai, finding its manufacturing out of compliance for the valsartan API that has been recalled globally after being found to contain a suspected carcinogen. More: EU regulators blast China’s Zhejiang Huahai
read more